Effectiveness of using long-acting angiotensin II type 1 receptor blocker in Japanese obese patients with metabolic syndrome on morning hypertension monitoring by using telemedicine system (FUJIYAMA Study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of using long-acting angiotensin II type 1 receptor blocker in Japanese obese patients with metabolic syndrome on morning hypertension monitoring by using telemedicine system (FUJIYAMA Study)

Published:2014-01-16 Issue:7 Volume:36 Page:508-516
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Kinoshita Shunsuke,Ryuzaki Munekazu,Sone Masayoshi,Nishida Eiichi,Nakamoto Hidetomo,

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10641963.2013.863325

Reference37 articles.

1. Effect of Telmisartan and Amlodipine on Home Blood Pressure by Monitoring Newly Developed Telemedicine System: Monitoring Test by Using Telemedicine. Telmisartan's Effect on Home Blood Pressure (TelTelbosu)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritoneal dialysis care by using artificial intelligence (AI) and information technology (IT) in Japan and expectations for the future;Renal Replacement Therapy;2023-07-04

2. Telmisartan Improves Insulin Resistance;American Journal of Therapeutics;2018-11

3. A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension;Clinical and Experimental Hypertension;2018-03-28

4. Metabolic syndrome in hypertensive patients: An unholy alliance;World Journal of Cardiology;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP